Oleamide.
May promote relaxation and support sleep quality, but evidence is limited. Supposed to help you relax and fall asleep. It interacts with some of the same brain systems as cannabis and sleeping pills, but much more weakly.
Reviewed March 2026
- Category
- Fatty acid
- Also filed under
- May promote relaxationMay improve sleep quality
What Oleamide is, and what it does.
- Does it work
- No. The theory is interesting, but the human evidence isn't there yet. There are better, more reliable options for sleep.
- How much to take
- Doses aren't well established. Most products offer 100-300 mg before bed. It's unclear if this is an effective dose for humans.
- Time to feel it
- It is taken in the evening, so any effect would land within an hour or two. No human trial has measured onset, so that window comes from the animal work.
- The first dose
- Probably nothing. A small percentage of people might feel a slight calm, but don't count on it. It's not a fast-acting supplement.
- With regular use
- Unknown. The goal is better sleep, but there's no solid data on long-term effects or benefits. Tolerance could be an issue.
- How well tolerated
- Seems okay for most, but the data is thin. The usual warning applies: avoid if pregnant, breastfeeding, or on medications affecting the central nervous system.
- How it feels
- A roll of the dice. Either a very subtle relaxation that's easy to miss, or absolutely no effect at all. It is not a 'knock you out' supplement.
- The overlooked benefit
- It competes with anandamide for the same clearance enzyme, so it can shift endocannabinoid tone indirectly without binding a cannabinoid receptor itself.
100 to 300mg a day is where Oleamide works.
Source: Cravatt et al., Science, 1995; Mendelson & Basile, Neuropsychopharmacology, 2001
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
The research is limited, with a mix of in-vitro, animal, and small human studies. Results are inconsistent, and more robust clinical trials are needed to confirm its efficacy in humans.
- sleep associated lipid signallingAnimal study
- positive allosteric modulation at GABA-A receptorsIn vitro study
- endocannabinoid tone through shared clearance with anandamideIn vitro study
- relaxation and evening wind downNarrative review
Questions people ask about Oleamide.
- Will oleamide make me feel high?
- No. While it interacts with cannabinoid receptors, it's not psychoactive and won't produce a high.
- Is it addictive?
- Unlikely to be addictive, but the research is limited. Given its weak effects, dependence is not a major concern.
- Can I take it with melatonin?
- It's probably fine, but start with one or the other. Combining sleep aids can lead to next-day grogginess.
- Will it help with anxiety?
- Maybe slightly, through its relaxing properties, but it's not studied or recommended for anxiety. There are better options.
- Is oleamide the same as olive oil?
- No. Oleamide is made from oleic acid, a component of olive oil, but they are chemically different compounds with different effects.
- How long does it take to work?
- If it works for you, you might notice something within an hour. For many, it never works.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Melatonin acts on MT1 and MT2 receptors to shift sleep timing, while oleamide is a fatty acid amide studied for its influence on GABA-A and endocannabinoid signalling. The two reach the same behavioural territory by unrelated routes, which is why they appear in the same night-time formulas. No study has measured them together.
Oleamide has been reported to act as a positive allosteric modulator at GABA-A receptors in laboratory preparations. Supplemental GABA is the receptor's own agonist, though its passage across the blood-brain barrier is limited. Pairing a modulator with an agonist is mechanistically coherent and has not been tested in people.
Theanine influences glutamatergic tone and raises alpha-band activity in human recordings. Oleamide works on a separate lipid-signalling system. Formulators combine them for calm-focus positioning; the pairing itself is untested.
Magnesium is a physiological NMDA receptor blocker and a GABA-A modulator at the same broad site oleamide is proposed to act on. The combination targets one receptor complex from two directions. Nothing has measured the pair.
Valerian constituents interact with GABA-A and adenosine signalling. Stacked with oleamide the sedation-leaning effects can add rather than cancel. That is a caution for anyone combining several calming ingredients in one dose, not a benefit claim.
Passionflower flavonoids are described as GABA-A modulators in preclinical work. Combined with oleamide the sedative direction is shared. No combination data exists in humans.
Apigenin binds at the benzodiazepine site of the GABA-A complex in binding assays. Oleamide is reported to modulate the same receptor at a different site. Two modulators at one receptor complex is an additive setup worth flagging.
Chamomile carries apigenin and is the traditional carrier of that activity. Its pairing with a fatty acid amide in a night formula is a formulation convention. There is no combination trial.
Honokiol and magnolol are described as GABA-A modulators in preclinical work. Layered with oleamide the calming direction compounds. Untested as a pair.
Lemon balm constituents inhibit GABA transaminase in vitro, which raises local GABA availability. That sits upstream of the receptor oleamide is proposed to modulate. The pairing is coherent on paper only.
Oleamide is a long-chain fatty acid amide with very low water solubility and dissolves readily in a lipid carrier. Suspending it in medium-chain triglycerides gives a dosing vehicle and supports micellar uptake in the gut. This is formulation physics, not a claimed biological synergy.
Phospholipids emulsify poorly soluble lipids and help them form mixed micelles for absorption. A lipophilic amide such as oleamide behaves like other fat-soluble actives in this respect. The benefit is on dispersion, which is measurable in a dissolution test rather than in a clinical endpoint.
Sunflower lecithin gives the same phospholipid emulsification without soy allergen labelling. For a lipophilic amide this is the same physical function in a different feedstock. Choice between the two is a sourcing decision.
Phosphatidylcholine is the specific phospholipid doing most of the emulsifying work in a lecithin blend and is also a bile constituent. It helps disperse lipophilic actives into the micellar phase. Nothing here implies a pharmacological interaction.
Fatty acid amide hydrolase degrades a family of fatty acid amides and ethanolamides, and long-chain polyunsaturated fatty acids feed the ethanolamide side of that pool. Loading one substrate class can occupy the same degradative enzyme. This is a plausible substrate-level interaction, not a measured one.
Caffeine blocks adenosine receptors and works against the direction oleamide is used for. Taking them close together works at cross purposes. This is worth flagging as a timing conflict in a stack rather than a chemical interaction.
Oleamide has been reported to interact with 5-HT receptor subtypes in preclinical preparations, and 5-HTP raises serotonin availability upstream of those receptors. Combining a precursor with a receptor-level modulator pushes on one system twice. No human data covers the pair.
Glycine acts at its own inhibitory receptor and lowers core temperature before sleep in human work. Oleamide reaches similar territory through a lipid-signalling route. The two are combined in formulas without a study behind the combination.
Talk to a doctor before taking Oleamide if any of these apply to you: Pregnancy, Breastfeeding, Liver conditions, Medications affecting GABA or serotonin. These are flags to check first, not effects Oleamide is known to cause.
Not medical advice. Show the label to your pharmacist.What Oleamide actually does.
Oleamide is cis-9-octadecenamide, the primary fatty acid amide of oleic acid, and it occurs endogenously in mammals including in cerebrospinal fluid.
Oleamide is hydrolysed to oleic acid and ammonia by fatty acid amide hydrolase, the same enzyme that degrades anandamide and other fatty acid ethanolamides.
As a long-chain lipid amide oleamide is essentially insoluble in water and lipophilic, so uptake depends on dietary fat and micelle formation in the small intestine.
Because it shares that degradative enzyme with anandamide, oleamide can act as a competing substrate, which is the usual explanation given for its indirect influence on endocannabinoid tone.
Where Oleamide comes from.
It starts as the same fatty acid found in olive oil. Chemists react that acid with ammonia to swap one part of the molecule, and the result is a waxy solid identical to a lipid your own body makes. Nothing is harvested from a plant in the finished form.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
The starting material is oleic acid, separated from a high-oleic vegetable oil such as olive, high-oleic sunflower or rapeseed by hydrolysis and fractionation. Some grades start from tallow-derived oleic acid, which is a labelling question for vegetarian formulas.
Oleic acid is reacted with ammonia at raised temperature and pressure, replacing the acid hydroxyl with an amide nitrogen and driving off water. Catalytic and dehydration-assisted variants of this step are both in commercial use.
The crude amide is separated from unreacted acid, nitrile side products and other chain lengths, usually by vacuum distillation, then crystallised or flaked.
Chromatography sets amide purity and confirms the cis configuration; residual free fatty acid and iodine value are the common release checks.
Sold as a waxy flake or bead for blending, or pre-dispersed in a carrier oil for softgel filling.
The forms it comes in.
The essence, in one line each.
- Over 12 weeks, 60 micrograms a day of oleamide raised memory test scores, including immediate and delayed free recall, compared with placebo in 58 healthy Japanese adults aged 50 to 75, and self-rated sleep quality and sleep latency improved within the oleamide group.Randomised trial. Sasaki et al., 2024 (Frontiers in Nutrition). PMID 38600994 ↗
- Neonatal oleamide supplementation during suckling reduced neurological changes caused by maternal sleep interruption in the animals studied; the result is in rodents and does not carry over to human supplementation.Animal study. Qian L et al., 2025 (Frontiers in Nutrition). PMID 40421035 ↗
- An ethanolic root extract of Rosa rugosa and its constituent oleamide reduced amyloid beta related measures in the model used; amyloid burden is a laboratory marker measured in non-human tissue.Animal study. Park CK et al., 2025 (International Journal of Molecular Sciences). PMID 40362451 ↗
- The trial tested two probiotic strains and reported a lowering of triglycerides; oleamide appears only as a named metabolite in the analysis, so this is not a test of oleamide.Randomised trial. Ahn HY et al., 2015 (Nutrition, Metabolism and Cardiovascular Diseases). PMID 26044516 ↗
- Oleamide appears among the metabolites detected in human breast milk and infant gut samples in this pilot; the reported relationships are associations within a small observational sample, not effects of taking oleamide.Cohort study. Gutierrez AS et al., 2026 (Physiological Reports). PMID 41776817 ↗
- Metabolomic screening identified oleamide among metabolites that differed by fertility status in the animals sampled; this is an association in a screening study, not a demonstrated effect.Animal study. Ning R et al., 2026 (Frontiers in Nutrition). PMID 42239712 ↗
- Oleamide is reported as one of the gut-microbiota-linked metabolites shifted by dietary inulin in the animals studied; the intervention tested was inulin, not oleamide.Animal study. Li K et al., 2025 (PLoS One). PMID 41264657 ↗
These are the studies our verdict leans on, chosen from the 617 we read for Oleamide. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.